Success Stories: Chinese Postdoctoral Fellow in Illinois in the Field of Biomedical Sciences Secures EB-1A Petition Approval in Just 2 Days

 

Client’s Testimonial:

“Thanks for all your effort and help on my case.”


On September 2nd, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Biomedical Sciences (Approval Notice).


 

General Field: Biomedical Sciences

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: China

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Illinois

Approval Notice Date: September 2nd, 2016

Processing Time: 2 Days (Premium Processing Requested)


Case Summary:

Our client’s Ph.D. in Genomics and Drug Discovery served as proof that he is armed with the knowledge and skills required to carry out impactful research in the field of biomedical sciences. Even so, when he approached us for help to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf, we carefully evaluated his credentials to be sure that we could build a strong case for him. After confirming that we could, an attorney-client relationship was established and we got to work on our client’s case.

There is no denying that putting together a strong EB-1A petition is no easy feat. It took us several months in total but judging from the approval notice that our client received merely 2 days after filing, we did an excellent job. The meticulous effort that we put into presenting our client’s solid credentials was not the only thing that accounted for the short wait time—it was mostly thanks to Premium Processing (PP), an add-on option offered by the USCIS that allows petitioners to have their cases processed within 15 calendar days instead of the usual 4-9 months. In any case, we have no doubt that our client’s strong petition paved the way for case approval. These are some of the highlights:

  • We noted our client’s 6 publications, the 17 times he assessed the work of his peers, and the 193 times his work was cited by other researchers.
  • Furthermore, we incorporated recommendation letters volunteered by other influential members of the biomedical sciences research community. According to one of them: “Given his high research productivity and continuous record of novel discovery, I can confidently state that [Client] is at the forefront of his field and will continue to produce foundational work in the worldwide realm of biomedical research, particularly within the specialized arena of molecular immunity.”
  • We duly documented our client’s work on elucidating the role of transcription factor Miz1 and the part it plays in acute lung injury, precisely how kinase JNK2 lends itself to stress-induced mitophagy, conducting incisive examinations on the E3 ligase Mule and its agency in inducing the activation of JNK, and the screening of natural compounds for viable anti-viral candidates, thereby fostering the incorporation of traditional Chinese medicine into the modern drug discovery pipeline for critical vaccine implementation. We proved to the USCIS that our client’s research addresses some of the US’ most pressing issues in understanding the underlying molecular machinery that drives inflammation resolution and cellular death.
We congratulate our client for surpassing this significant hurdle in the green card process. He is now closer to a green card and we wish him the best as he files I-485 applications for himself and his wife. Once the USCIS approves their applications, they will become American permanent residents. Till then, we bid him well as he continues to conduct important research in the field of biomedical sciences.